NCT02159027 - Maraviroc and NeuroAIDS Pathogenesis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions

AIDS Dementia Complex

Interventions

DRUG

Maraviroc

Maraviroc administered twice daily, dosage based on concomitant medication being taken.

DRUG

Placebo

Maraviroc placebo administered twice daily, dosage based on concomitant medication being taken.

Trial Locations (2)

Clint Spencer Clinic, Hawaii Center for AIDS, University of Hawaii, Honolulu

Puerto Rico Clinical and Translational Research Consortium, San Juan